Blanc, 179 patient metformin prophylaxis study: 79% lower mortality [p=0.06] and 44% more cases [p=0.12] https://c19p.org/blanc
copied to clipboard
Therapeutic prevention of COVID-19 in elderly: a case–control study
et al., GeroScience, doi:10.1007/s11357-021-00397-z
Retrospective 179 patients in France exposed to COVID-19 showing, without statistical significance, a higher risk of cases, and a lower risk of mortality among cases with existing metformin treatment.
|
risk of death, 78.6% lower, RR 0.21, p = 0.06, treatment 1 of 14 (7.1%), control 25 of 75 (33.3%), NNT 3.8, COVID+.
|
|
risk of case, 43.7% higher, RR 1.44, p = 0.12, treatment 11 of 16 (68.8%), control 78 of 163 (47.9%).
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Blanc et al., 7/17/2021, retrospective, France, Europe, peer-reviewed, 22 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.